Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026)
Elutia (ELUT) reported Total Non-Current Liabilities of $29.3 million for Q1 2026, down 58.75% on a YoY basis from $71.0 million in Q1 2025, and down 7.17% sequentially from $31.6 million in Q4 2025.
Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Total Non-Current Liabilities data on file, last reported at $29.3 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities fell 58.75% year-over-year to $29.3 million; the trailing twelve-month figure through Mar 2026 stood at $29.3 million (down 58.75% YoY), and the FY2025 full-year result was $31.6 million, down 52.42% from the prior year.
- Total Non-Current Liabilities declined to $29.3 million in Q1 2026, from $31.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $104.7 million in Q2 2024 to a low of $29.3 million in Q1 2026.
- A 5-year average of $66.7 million and a median of $71.0 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities soared 101.78% in 2022 and tumbled 58.75% in 2026, its largest moves.
- Tracing ELUT's Total Non-Current Liabilities over 5 years: stood at $73.7 million in 2022, then fell by 6.07% to $69.3 million in 2023, then slipped by 4.27% to $66.3 million in 2024, then slumped by 52.42% to $31.6 million in 2025, then retreated by 7.17% to $29.3 million in 2026.
- Business Quant data shows ELUT's Total Non-Current Liabilities at $29.3 million in Q1 2026, $31.6 million in Q4 2025, and $69.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn | 29.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.29 Mn |
| Dec 31, 2025 | 31.55 Mn |
| Sep 30, 2025 | 69.30 Mn |
| Jun 30, 2025 | 66.73 Mn |
| Mar 31, 2025 | 71.02 Mn |
| Dec 31, 2024 | 66.31 Mn |
| Sep 30, 2024 | 82.40 Mn |
| Jun 30, 2024 | 104.67 Mn |
| Mar 31, 2024 | 78.00 Mn |
| Dec 31, 2023 | 69.27 Mn |
| Sep 30, 2023 | 83.62 Mn |
| Jun 30, 2023 | 74.11 Mn |
| Mar 31, 2023 | 72.60 Mn |
| Dec 31, 2022 | 73.75 Mn |
| Sep 30, 2022 | 71.62 Mn |
| Jun 30, 2022 | 53.32 Mn |
| Mar 31, 2022 | 36.85 Mn |
| Dec 31, 2021 | 52.95 Mn |
| Sep 30, 2021 | 35.49 Mn |
| Jun 30, 2021 | 38.15 Mn |